TEAR - TearLab Corporation Stock Price, News & Analysis

$0.72 0.01 (1.41 %)
(As of 11/24/2017 02:32 AM ET)
Previous Close$0.72
Today's Range$0.73 - $0.71
52-Week Range$0.59 - $7.50
Volume34,701 shs
Average Volume161,467 shs
Market Capitalization$4.10 million
P/E RatioN/A
Dividend YieldN/A
Beta2.92

About TearLab Corporation (OTCMKTS:TEAR)

TearLab Corporation logoTearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.


Industry, Sector and Symbol

Industry Glasses, Spectacles & Contact lenses
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:TEAR
  • Previous Symbol: NASDAQ:TEAR
  • CUSIPN/A

    Debt

    Debt-to-Equity Ratio-1.62%
    Current Ratio2.19%
    Quick Ratio1.75%

    Price-To-Earnings

    Trailing P/E RatioN/A
    Forward P/E RatioN/A
    P/E GrowthN/A

    Sales & Book Value

    Annual Sales$28.01 million
    Price / Sales0.15
    Cash FlowN/A
    Price / CashN/A
    Book Value($2.99) per share
    Price / Book-0.24

    Dividend

    Annual DividendN/A
    Dividend YieldN/A

    Profitability

    Trailing EPS($2.98)
    Net Income$-19,920,000.00
    Net Margins-60.22%
    Return on EquityN/A
    Return on Assets-75.54%

    Miscellaneous

    Employees75
    Outstanding Shares5,740,000

    Frequently Asked Questions for TearLab Corporation (OTCMKTS:TEAR)

    What is TearLab Corporation's stock symbol?

    TearLab Corporation trades on the OTCMKTS under the ticker symbol "TEAR."

    When did TearLab Corporation's stock split? How did TearLab Corporation's stock split work?

    Shares of TearLab Corporation reverse split before market open on Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of TearLab Corporation stock prior to the reverse split would have 10 shares after the split.

    How were TearLab Corporation's earnings last quarter?

    TearLab Corporation (OTCMKTS:TEAR) issued its earnings results on Monday, November, 13th. The medical research company reported ($0.67) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.73) by $0.06. The medical research company earned $6.52 million during the quarter, compared to analysts' expectations of $6.80 million. View TearLab Corporation's Earnings History.

    When will TearLab Corporation make its next earnings announcement?

    TearLab Corporation is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for TearLab Corporation.

    Where is TearLab Corporation's stock going? Where will TearLab Corporation's stock price be in 2017?

    4 brokers have issued twelve-month price objectives for TearLab Corporation's shares. Their predictions range from $4.00 to $9.00. On average, they expect TearLab Corporation's stock price to reach $5.75 in the next year. View Analyst Ratings for TearLab Corporation.

    Who are some of TearLab Corporation's key competitors?

    Who are TearLab Corporation's key executives?

    TearLab Corporation's management team includes the folowing people:

    • Elias Vamvakas, Chairman of the Board (Age 58)
    • Joseph S. Jensen, President, Chief Executive Officer, Chief Operating Officer, Director (Age 45)
    • Wes Brazell, Chief Financial Officer (Age 51)
    • Raymond Kong, Vice President - Sales
    • Anthony E. Altig, Independent Director (Age 61)
    • Thomas N. Davidson Jr., Independent Director (Age 57)
    • Adrienne L. Graves Ph.D., Independent Director (Age 63)
    • Paul M. Karpecki, Independent Director (Age 49)
    • Richard L. Lindstrom M.D., Independent Director (Age 69)

    How do I buy TearLab Corporation stock?

    Shares of TearLab Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is TearLab Corporation's stock price today?

    One share of TearLab Corporation stock can currently be purchased for approximately $0.72.

    How big of a company is TearLab Corporation?

    TearLab Corporation has a market capitalization of $4.10 million and generates $28.01 million in revenue each year. The medical research company earns $-19,920,000.00 in net income (profit) each year or ($2.98) on an earnings per share basis. TearLab Corporation employs 75 workers across the globe.

    How can I contact TearLab Corporation?

    TearLab Corporation's mailing address is 9980 Huennekens Street Suite 100, San Diego CA, 92121. The medical research company can be reached via phone at 858-455-6006 or via email at [email protected]


    MarketBeat Community Rating for TearLab Corporation (TEAR)

    Community Ranking:  3.4 out of 5 (star star star)
    Outperform Votes:  226 (Vote Outperform)
    Underperform Votes:  110 (Vote Underperform)
    Total Votes:  336
    MarketBeat's community ratings are surveys of what our community members think about TearLab Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for TearLab Corporation (OTCMKTS:TEAR)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 4 Buy Ratings, 0 Strong Buy Ratings
    Consensus Rating:Buy (Score: 3.00)
    Consensus Price Target: $5.75

    Consensus Price Target History for TearLab Corporation (OTCMKTS:TEAR)

    Price Target History for TearLab Corporation (OTCMKTS:TEAR)

    Analysts' Ratings History for TearLab Corporation (OTCMKTS:TEAR)

    Show:
    DateFirmActionRatingPrice TargetDetails
    8/15/2017HC WainwrightReiterated RatingBuy$4.00View Rating Details
    5/16/2017Rodman & RenshawLower Price TargetBuy -> Buy$12.00 -> $4.00View Rating Details
    3/11/2017Craig HallumSet Price TargetBuy$6.00View Rating Details
    3/11/2017Feltl & Co.DowngradeStrong-Buy -> Buy$9.00View Rating Details
    8/4/2016Roth CapitalDowngradeBuy -> NeutralView Rating Details
    3/9/2016Canaccord GenuityReiterated RatingBuyView Rating Details
    (Data available from 11/24/2015 forward)

    Earnings

    Earnings History and Estimates Chart for TearLab Corporation (OTCMKTS:TEAR)

    Earnings by Quarter for TearLab Corporation (OTCMKTS:TEAR)

    Earnings History by Quarter for TearLab Corporation (OTCMKTS TEAR)

    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    3/8/2018        
    11/13/2017Q3 2017($0.73)($0.67)$6.80 million$6.52 millionViewN/AView Earnings Details
    8/14/2017Q2 2017($0.75)($0.68)$6.86 million$7.00 millionViewN/AView Earnings Details
    5/15/2017Q1 2017($0.75)($0.82)$7.02 million$6.70 millionViewN/AView Earnings Details
    3/9/2017Q4 2016($0.90)($0.81)$7.71 million$7.12 millionViewListenView Earnings Details
    11/7/2016Q316($0.08)($0.07)$7.13 million$20.90 millionViewListenView Earnings Details
    8/3/2016Q2($0.08)($0.08)$6.95 million$6.90 millionViewN/AView Earnings Details
    5/4/2016Q1($0.23)($0.21)$6.53 million$6.80 millionViewN/AView Earnings Details
    3/8/2016Q4($0.25)($0.26)$6.83 million$6.80 millionViewN/AView Earnings Details
    11/5/2015Q315($0.24)($0.24)$6.40 million$6.60 millionViewN/AView Earnings Details
    8/6/2015Q215($0.25)($0.24)$5.72 million$6.30 millionViewN/AView Earnings Details
    5/7/2015Q115($0.21)($0.25)$5.40 million$5.40 millionViewN/AView Earnings Details
    3/12/2015Q414($0.17)($0.21)$5.50 million$5.30 millionViewN/AView Earnings Details
    11/5/2014Q214($0.17)($0.17)$5.50 million$5.20 millionViewN/AView Earnings Details
    8/7/2014Q114($0.16)($0.17)$5.12 million$9.20 millionViewN/AView Earnings Details
    5/8/2014Q1($0.14)($0.17)$4.76 million$4.21 millionViewN/AView Earnings Details
    3/13/2014Q413($0.13)($0.13)$4.49 million$4.40 millionViewN/AView Earnings Details
    11/12/2013Q3($0.14)($0.13)$3.80 million$4.20 millionViewListenView Earnings Details
    5/13/2013Q1 2013($0.12)($0.30)$2.18 million$2.47 millionViewN/AView Earnings Details
    11/13/2012Q312($0.11)($0.10)$1.20 millionViewN/AView Earnings Details
    (Data available from 1/1/2011 forward)

    Estimates

    Earnings Estimates for TearLab Corporation (OTCMKTS:TEAR)
    Current Year EPS Consensus Estimate: $-2.64 EPS
    Next Year EPS Consensus Estimate: $-1.36 EPS

    Dividends

    Dividend History for TearLab Corporation (OTCMKTS:TEAR)
    No dividend announcements for this company have been tracked by MarketBeat.com

    Insider Trades

    Insider Trading and Institutional Ownership History for TearLab Corporation (OTCMKTS TEAR)

    Insider Ownership Percentage: 12.00%
    Institutional Ownership Percentage: 19.78%
    Insider Trades by Quarter for TearLab Corporation (OTCMKTS:TEAR)
    Insider Trades by Quarter for TearLab Corporation (OTCMKTS:TEAR)

    Insider Trades by Quarter for TearLab Corporation (OTCMKTS TEAR)

    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    3/30/2017Awm Investment Company, Inc.Major ShareholderSell327,674$3.20$1,048,556.80View SEC Filing  
    5/31/2016Brock WrightDirectorBuy59,686$0.78$46,555.08View SEC Filing  
    5/26/2016Brock WrightDirectorBuy130,314$0.76$99,038.64View SEC Filing  
    12/4/2014Elias VamvakasCEOBuy50,000$2.24$112,000.00View SEC Filing  
    11/18/2014Elias VamvakasCEOBuy31,187$2.55$79,526.85View SEC Filing  
    11/17/2014Elias VamvakasCEOBuy18,813$2.55$47,973.15View SEC Filing  
    11/11/2014Elias VamvakasCEOBuy150,000$2.49$373,500.00View SEC Filing  
    11/10/2014Elias VamvakasCEOBuy16,276$2.50$40,690.00View SEC Filing  
    11/10/2014Joseph JensenCOOBuy43,375$2.31$100,196.25View SEC Filing  
    8/20/2014Brock WrightDirectorBuy23,000$3.82$87,860.00View SEC Filing  
    8/19/2014Brock WrightDirectorBuy11,354$3.83$43,485.82View SEC Filing  
    8/12/2014Elias VamvakasCEOBuy70,000$3.43$240,100.00View SEC Filing  
    6/30/2014Richard LindstromDirectorSell5,000$4.61$23,050.00View SEC Filing  
    5/13/2014Elias VamvakasCEOBuy30,000$3.99$119,700.00View SEC Filing  
    5/13/2014Joseph JensenCOOBuy48,693$4.11$200,128.23View SEC Filing  
    4/1/2014Paul KarpeckiDirectorSell5,000$6.83$34,150.00View SEC Filing  
    1/2/2014Paul KarpeckiDirectorSell5,000$9.47$47,350.00View SEC Filing  
    12/31/2013Richard LindstromDirectorSell5,000$9.26$46,300.00View SEC Filing  
    11/15/2013Richard LindstromDirectorSell5,000$8.95$44,750.00View SEC Filing  
    10/11/2013Paul KarpeckiDirectorSell5,000$10.96$54,800.00View SEC Filing  
    9/3/2013William DumencuCFOSell7,000$13.22$92,540.00View SEC Filing  
    8/1/2013William DumencuCFOSell7,000$14.39$100,730.00View SEC Filing  
    7/1/2013Paul KarpeckiDirectorSell5,000$10.62$53,100.00View SEC Filing  
    7/1/2013William DumencuCFOSell7,000$10.61$74,270.00View SEC Filing  
    6/3/2013William DumencuCFOSell7,000$11.35$79,450.00View SEC Filing  
    4/2/2013Tom Jr. DavidsonDirectorBuy1,500$6.63$9,945.00View SEC Filing  
    (Data available from 1/1/2013 forward)

    Headlines

    Latest Headlines for TearLab Corporation (OTCMKTS TEAR)

    Source:
    DateHeadline
    Contrasting TearLab Corporation (TEAR) & Cooper Companies, Inc. (The) (COO)Contrasting TearLab Corporation (TEAR) & Cooper Companies, Inc. (The) (COO)
    www.americanbankingnews.com - November 17 at 9:23 AM
    Cooper Companies, Inc. (The) (COO) vs. TearLab Corporation (TEAR) Head to Head AnalysisCooper Companies, Inc. (The) (COO) vs. TearLab Corporation (TEAR) Head to Head Analysis
    www.americanbankingnews.com - November 17 at 8:36 AM
    Comparing TearLab Corporation (TEAR) and LightPath Technologies (LPTH)Comparing TearLab Corporation (TEAR) and LightPath Technologies (LPTH)
    www.americanbankingnews.com - November 16 at 9:54 PM
    Analyzing TearLab Corporation (TEAR) and Cooper Companies, Inc. (The) (COO)Analyzing TearLab Corporation (TEAR) and Cooper Companies, Inc. (The) (COO)
    www.americanbankingnews.com - November 16 at 3:50 PM

    Social Media

    Financials

    Chart

    TearLab Corporation (OTCMKTS TEAR) Chart for Friday, November, 24, 2017
    Loading chart…

    This page was last updated on 11/24/2017 by MarketBeat.com Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.